Last viewed:
RLFTY
Prices are updated after-hours
RLFTY
|
$1.4006
733.33%
100
|
n/a
(0.0% 1d)
(-10.0% 1m)
(-65.0% 1y)
(0.0% 2d)
(0.0% 3d)
(-2.1% 7d)
(-75.0%
volume)
Earnings Calendar:
Market Cap: $ 19,665,596
https://relieftherapeutics.com/c
Sec
Filling
|
Patents
| 3367 employees
(CH) aeris was founded with the aim of becoming a benchmark on the wind blade manufacturing and, to achieve this goal, has created a highly skilled team with the potential to add value and quality to the product and management and respond efficiently to the challenges of the market.
add to watch list
Paper trade
email alert is off
Press-releases
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
Published: 2024-03-22
(Crawled : 06:00)
- globenewswire.com
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -1.02%
| O: -3.07%
H: 18.31%
C: 12.54%
ETON
|
$3.295
1.39%
1.37%
23K
|
Health Technology
| -9.39%
| O: 6.08%
H: 5.73%
C: 3.13%
golike
acquisition
pharmaceuticals
phenylketonuria
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
Published: 2024-03-22
(Crawled : 08:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -1.02%
| O: -3.07%
H: 18.31%
C: 12.54%
ETON
|
$3.295
1.39%
1.37%
23K
|
Health Technology
| -9.39%
| O: 6.08%
H: 5.73%
C: 3.13%
license
pharmaceuticals
golike
therapeutics
agreement
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
Published: 2024-02-28
(Crawled : 09:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -21.62%
| O: -0.27%
H: 2.44%
C: -2.43%
million
therapeutics
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
Published: 2023-12-05
(Crawled : 10:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -33.24%
| O: 1.05%
H: 0.46%
C: -1.59%
partnership
commercial
therapeutics
growth
Relief Therapeutics Announces CEO Transition
Published: 2023-11-22
(Crawled : 09:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -33.79%
| O: -2.05%
H: 6.29%
C: 6.29%
ceo
therapeutics
Relief Therapeutics Announces that more than 400,000 of its ADRs are Currently Outstanding and that, as a Result, the Company has Achieved an Important NASDAQ Initial Listing Milestone
Published: 2023-10-10
(Crawled : 07:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -38.3%
| O: -1.79%
H: 0.0%
C: -0.78%
nasdaq
company
therapeutics
milestone
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update
Published: 2023-09-15
(Crawled : 12:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -59.15%
| O: -15.49%
H: 1.67%
C: -8.33%
RLFTY
|
$1.4006
733.33%
100
|
n/a
| -53.78%
| O: 0.33%
H: 0.0%
C: -7.73%
update
therapeutics
financial
results
Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-01
(Crawled : 10:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -53.67%
| O: 22.68%
H: 7.81%
C: 0.0%
RLFTY
|
$1.4006
733.33%
100
|
n/a
| -47.35%
| O: 34.59%
H: 6.59%
C: 6.59%
conference
global
therapeutics
Relief Therapeutics Announces Extension of Distribution Agreement for PKU GOLIKE(R) in the U.S. with Pentec Health
Published: 2023-07-19
(Crawled : 08:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -51.67%
| O: 3.0%
H: 2.91%
C: -2.91%
RLFTY
|
$1.4006
733.33%
100
|
n/a
| -54.08%
| O: -6.89%
H: 0.0%
C: 0.0%
health
distribution
extension
therapeutics
agreement
Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE(R) in the Middle East
Published: 2023-06-23
(Crawled : 08:00)
- biospace.com/
RLFTF
|
$1.45
11.45%
1.3K
|
n/a
| -59.72%
| O: -0.28%
H: 0.0%
C: -1.0%
RLFTY
|
$1.4006
733.33%
100
|
n/a
| -61.94%
| O: 0.0%
H: 0.0%
C: 0.0%
drug
distribution
therapeutics
agreement
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount